Trademark: 97107116
Status Date
Tuesday, November 7, 2023
Filing Date
Wednesday, November 3, 2021
Published for Opposition
Tuesday, January 3, 2023
41 business training services, namely, scientific and regulatory leadership development training for healthcare industry organizations, namely, biopharmaceutical organizations, contract research organizations, medical device companies, and hospitals; training and development in the field of conducting clinical trials, namely, conducting seminars and workshops in the field of clinical trials; training in the field of computer software support, namely, conducting seminars and workshops in the field of software support; none of the foregoing for in vitro diagnostics, detection of contaminants, infectious disease surveillance, disease prevention and control, and/or antimicrobial stewardship
9 downloadable computer software for use in collecting, managing and analyzing quality of life, subjective symptom, and similar self-observation data self-reported by patients in pharmaceutical clinical trials; downloadable computer software for the collection, interpretation, evaluation, auditing, management, processing, tracking and viewing of data in the field of clinical trials; downloadable computer software for calibrating and managing medical instruments used in clinical trials; none of the aforesaid goods relating to the custom design and development of computer hardware and software except as relating to medical research or medical clinical trials; none of the foregoing for in vitro diagnostics, detection of contaminants, infectious disease surveillance, disease prevention and control, and/or antimicrobial stewardship
35 computerized database management services in connection with clinical trials of medical and clinical diagnostic products; business consulting services in relation to clinical data and regulatory management for healthcare industry organizations, namely, biopharmaceutical organizations, contract research organizations, medical device companies, and hospitals; business consulting and management in the field of clinical trials, namely, providing information management services; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; providing independent review of clinical trials for business purposes; database management services, namely, aggregating and organizing data in connection with clinical trials of medical and clinical diagnostic products; none of the foregoing for in vitro diagnostics, detection of contaminants, infectious disease surveillance, disease prevention and control, and/or antimicrobial stewardship
10 medical devices for the respiratory system, namely, for measuring, monitoring, collecting, recording, transmitting, and evaluating data regarding expiratory flow, respiratory symptoms, and respiratory medication consumption; medical devices for measuring, monitoring, collecting, recording, transmitting, and evaluating data concerning expiratory flow and cardiopulmonary behavior; portable medical devices with sensors to monitor the physical movements of a patient wearing or carrying the device; medical apparatus and equipment for examining lung function and parts therefor; medical electronic apparatus and equipment, namely, spirometers, pulse oximeters, and electrocardiographs; integrated medical research systems comprising wearable devices with sensors, namely, accelerometers, gyroscopes, and magnetometers, to monitor the physical movements of an individual wearing the device and downloadable computer software and monitors used during the process of monitoring the movement of an individual; none of the foregoing for in vitro diagnostics, detection of contaminants, infectious disease surveillance, disease prevention and control, and/or antimicrobial stewardship
42 data automation and collection service using proprietary software to evaluate, analyze, and collect data; consulting services in the field of clinical trials of medical and clinical diagnostic products; design and development of computer software for collecting, storing, managing, analyzing, and reporting on healthcare data and clinical trial data; providing temporary use of non-downloadable computer software for collecting, storing, managing, analyzing, and reporting on healthcare data and clinical trial data; design and development of computer software for data analytics, data visualization, and data workflow in the healthcare and pharmaceutical industries; providing temporary use of non-downloadable computer software for data analytics, data visualization, and data workflow in the healthcare and pharmaceutical industries; data automation and collection service using proprietary software to evaluate, analyze and collect service data; providing temporary use of non-downloadable software for use in screening and monitoring patients for suicide risk; providing temporary use of non-downloadable software for measuring expiratory flow volume and monitoring, collecting, and evaluating expiratory flow data; application service provider services featuring software for the collection, management and reporting by others of clinical research and marketing; providing a database featuring medical and scientific research information pertaining to clinical trials of pharmaceuticals; providing a website featuring medical and scientific research information pertaining to clinical trials of pharmaceuticals; providing medical and scientific research information in the field of clinical trials; laboratory services, namely, imaging core lab services; technical consulting services in the field of clinical trials; providing an on-line computer database in the field of clinical trials; none of the aforesaid services relating to the custom design and development of computer hardware and software except as relating to medical research or medical clinical trials; none of the foregoing for in vitro diagnostics, detection of contaminants, infectious disease surveillance, disease prevention and control, and/or antimicrobial stewardship
Apr 8, 2024
Case Assigned To Intent To Use Paralegal
Mar 20, 2024
Teas Request To Divide Received
Mar 20, 2024
Teas Statement Of Use Received
Mar 20, 2024
Sou Teas Extension Received
Nov 22, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Nov 22, 2023
Teas Change Of Correspondence Received
Nov 22, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 22, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 22, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 22, 2023
Teas Change Of Owner Address Received
Nov 7, 2023
Noa E-Mailed - Sou Required From Applicant
Sep 25, 2023
Ttab Release Case To Trademarks
Sep 25, 2023
Opposition Terminated No. 999999
Sep 25, 2023
Opposition Dismissed No. 999999
Jun 26, 2023
Opposition Instituted No. 999999
May 23, 2023
Changes/Corrections After Pub Approval Entered
May 22, 2023
Assigned To Petition Staff
May 4, 2023
Teas Post Publication Amendment Received
Jan 20, 2023
Extension Of Time To Oppose Received
Jan 3, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 3, 2023
Published For Opposition
Dec 14, 2022
Notification Of Notice Of Publication E-Mailed
Nov 29, 2022
Approved For Pub - Principal Register
Nov 29, 2022
Examiner's Amendment Entered
Nov 29, 2022
Notification Of Examiners Amendment E-Mailed
Nov 29, 2022
Examiners Amendment E-Mailed
Nov 29, 2022
Examiners Amendment -Written
Nov 25, 2022
Previous Allowance Count Withdrawn
Oct 25, 2022
Withdrawn From Pub - Og Review Query
Oct 13, 2022
Electronic Record Review Complete
Oct 7, 2022
On Hold - Electronic Record Review Required
Oct 3, 2022
Approved For Pub - Principal Register
Aug 23, 2022
Teas/Email Correspondence Entered
Aug 22, 2022
Correspondence Received In Law Office
Aug 22, 2022
Teas Response To Office Action Received
Aug 22, 2022
Notification Of Non-Final Action E-Mailed
Aug 22, 2022
Non-Final Action E-Mailed
Aug 22, 2022
Non-Final Action Written
Aug 12, 2022
Assigned To Examiner
Mar 18, 2022
Teas Amendment Entered Before Attorney Assigned
Mar 18, 2022
Teas Voluntary Amendment Received
Nov 15, 2021
New Application Office Supplied Data Entered
Nov 6, 2021
Teas Change Of Correspondence Received
Nov 6, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 6, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 6, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
